Are you facing challenges in quickly bringing new healthtech products to market? The NHS is a large and complex system and ...

The research, which will be presented to delegates at the ISPOR conference in Barcelona, Spain, examined NICE technology appraisal and highly specialised technologies guidance published between June ...

We use tools such as Google Analytics, Hotjar, Google Optimize and Loop11 to help us anonymously measure how you use our websites. This allows us to make improvements based on our users' needs.

CHEERS-AI builds on existing best practice in health economic evaluation reporting by including the original 28 standards ...

The London School of Economics and Political Science (LSE) have joined forces with NICE to offer a unique solution - the Executive MSc in Healthcare Decision-Making.

We have also today published a new discussion aid to support shared decision making about HRT, focusing on the key risks and benefits to consider. The guideline clarifies that whilst HRT has some ...

Your organisation needs to be registered as a stakeholder before we can accept comments. Not eligible? Contact the stakeholder organisation that most closely represents your interests and pass your ...

There is a simple discount patient access scheme for avapritinib. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non‑NHS organisations can contact ...

Around 5.3 million people in England were given a NICE-recommended statin or ezetimibe by their GP to help reduce their cholesterol during 2023/24, the largest number on record and almost 900,000 more ...

You should read both the consultation document and the accompanying evidence (see the committee papers) before making any comments. You must make your comments ...

The guideline recommends that for some women, trans men and non-binary people registered female at birth, additional advice should be sought from a healthcare professional with expertise in menopause ...